Mechanisms,strategies,and clinical advances in tumor immunotherapyLI Weina, LEI Xiaoying, LI Meng, ZHANG Yingqi1401-1408
From misjudgment to confirmation:a four-decade revision of absolute configuration of mefloquine hydrochloride and its implications for military pharmaceutical researchZHOU Gang, WEI Zhao, NIE Huifang, LI Muqiong, XI Jiayue, WANG Ping'an1409-1414
Impact of configuration differences of chiral ZnO nanoparticles on its frostbite treatment effectWANG Chaoli, QIAO Youbei, GAO Hao, SUN Chun, ZHAI Yuan, YANG Changbin, CHEN Peng1415-1420
Stability study of three injectable combat medicines under high-temperature conditionsWANG Wei, ZHU Yanrong, GUAN Shuxin, XIN Chunyan, WANG Yuxiang, LI Chen, GE Xu1421-1424,1432
Therapeutic effects of T7 peptide-modified ultra-small polydopamine nanoparticles on traumatic brain injuryQIN Jiale, YI Chunlin, LI Han, CUI Hao, GONG Wenshuai, WU Hongyan, ZHOU Siyuan, LIU Daozhou1425-1432
Exploring the molecular mechanism of Jia-Jian-Jie-Du Decoction in the treatment of Japanese encephalitis based on network pharmacologyQI Wenhui, LI Chengwen, LI Xiaoqiang, SONG Fan1433-1441
Quantification of antigen loading efficiency in nanoadjuvant-antigen covalent conjugatesCUI Minxuan, SHI Zhuoyue, XI Jiayue, ZHU Yupu, MA Zhengjun, SONG Chaojun, FAN Li1442-1449
Data mining of adverse drug event signals for pembrolizumab based on FAERSCUI Yu, WANG Suzhen, GAO Yuxuan, YU Lili1450-1455
Safety assessment of eltrombopag:real-world adverse event analysis from the FAERS databaseLIU Jie, CHEN Shupeng, GAO Yao, ZHANG Meiling, WU Zhenhui, ZENG Yingjian1456-1464
Construction of a universal,efficient and multi-epitope vaccine design and development platform for pathogensWANG Shuning, LI Weina, ZHANG Wangqian, DU Haichen, LIU Lijun, XIANG An, LI Meng, ZHANG Yingqi, ZHANG Cun1465-1472,1480